Glucotrack, Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Rutherford, NJ
GCTK chart
What traders are saying about $GCTK
Latest postsGlucotrack, Inc. news
- Technical Analysis of GlucoTrack, Inc. (OTC:GCTK)
TradingView ·
- Glucotrack, Inc. Announces Reverse Stock Split
Yahoo Finance ·
- Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
Yahoo Finance ·
- Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
Yahoo Finance ·
- Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
Yahoo Finance ·
- Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
Yahoo Finance ·
- Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
Yahoo Finance ·
- Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform
Yahoo Finance ·
- Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
Yahoo Finance ·
- Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
Yahoo Finance ·
- Glucotrack Announces $11.5 Million Financing
Yahoo Finance ·
- Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions
Yahoo Finance ·
Glucotrack, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$19.4M | -$22.6M | -$7.1M | -$4.4M |
| Diluted EPS | $31.22 | $4106.00 | $34.18 | $0.29 |
| Total assets (year end) | $7.8M | $5.9M | $4.9M | $2.4M |
| Cash and equivalents (year end) | $7.4M | $5.6M | $4.5M | $2.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Glucotrack, Inc.
- Ticker
- GCTK (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Rutherford, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1506983
- Former names
- Integrity Applications, Inc.
Frequently asked questions
What exchange is Glucotrack, Inc. listed on?
Glucotrack, Inc. trades on the Nasdaq under the ticker symbol GCTK.
What industry is Glucotrack, Inc. in?
Glucotrack, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Glucotrack, Inc. headquartered?
Glucotrack, Inc.'s business address on file with the SEC is in Rutherford, NJ.
When does Glucotrack, Inc.'s fiscal year end?
Glucotrack, Inc.'s fiscal year ends on December 31.
How much revenue did Glucotrack, Inc. report?
Glucotrack, Inc. reported $208,000 in revenue for calendar year 2019, according to its SEC filings.